HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhangjun Cheng Selected Research

Cholangiocarcinoma

1/2023Prognostic value of lymphadenectomy in node-negative intrahepatic cholangiocarcinoma: A multicenter, retrospectively study.
1/2023Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma.
3/2022Recurrence and prognosis in intrahepatic cholangiocarcinoma patients with different etiology after radical resection: a multi-institutional study.
1/2022Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription.
1/2022A Nomogram Model to Predict Early Recurrence of Patients With Intrahepatic Cholangiocarcinoma for Adjuvant Chemotherapy Guidance: A Multi-Institutional Analysis.
12/2021Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China.
4/2021Postoperative adjuvant transarterial chemoembolization for intrahepatic cholangiocarcinoma patients with microvascular invasion: a propensity score analysis.
1/2021Prediction Efficacy of Prognostic Nutritional Index and Albumin-Bilirubin Grade in Patients With Intrahepatic Cholangiocarcinoma After Radical Resection: A Multi-Institutional Analysis of 535 Patients.
12/2019Modifications of the AJCC 8th edition staging system for intrahepatic cholangiocarcinoma and proposal for a new staging system by incorporating serum tumor markers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhangjun Cheng Research Topics

Disease

17Hepatocellular Carcinoma (Hepatoma)
10/2023 - 08/2015
16Neoplasms (Cancer)
02/2024 - 08/2015
9Cholangiocarcinoma
01/2023 - 12/2019
8Neoplasm Metastasis (Metastasis)
01/2023 - 08/2009
5Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 08/2009
4Liver Neoplasms (Liver Cancer)
12/2022 - 01/2019
4Carcinogenesis
01/2022 - 08/2015
2Liver Failure
01/2022 - 01/2021
2Inflammation (Inflammations)
12/2021 - 06/2016
2Fibrosis (Cirrhosis)
01/2021 - 05/2015
1Infections
02/2024
1Non-alcoholic Fatty Liver Disease
11/2023
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2023
1Obstructive Jaundice (Cholestatic Jaundice)
01/2021
1Rupture
01/2019
1Liver Diseases (Liver Disease)
01/2018
1Pathologic Processes
01/2017
1Diabetes Mellitus
06/2016
1Thrombocytopenia (Thrombopenia)
07/2012
1Lymphatic Metastasis
08/2009

Drug/Important Bio-Agent (IBA)

4Long Noncoding RNAIBA
01/2023 - 12/2018
3RNA (Ribonucleic Acid)IBA
01/2023 - 12/2021
3Proteins (Proteins, Gene)FDA Link
01/2023 - 08/2009
2Immune Checkpoint InhibitorsIBA
02/2024 - 01/2023
2MicroRNAs (MicroRNA)IBA
10/2023 - 01/2021
2AlbuminsIBA
01/2021 - 01/2021
2BilirubinIBA
01/2021 - 01/2021
2Sorafenib (BAY 43-9006)FDA Link
12/2019 - 02/2019
2CateninsIBA
02/2019 - 08/2009
2Delta CateninIBA
01/2019 - 10/2012
1Carbon Tetrachloride (Tetrachloromethane)IBA
01/2023
1atezolizumabIBA
01/2023
1Bevacizumab (Avastin)FDA Link
01/2023
1Biomarkers (Surrogate Marker)IBA
01/2022
1lenvatinibIBA
01/2022
1Circular RNAIBA
01/2022
1MucinsIBA
01/2022
1GemcitabineFDA Link
01/2022
1Cisplatin (Platino)FDA LinkGeneric
01/2022
1MicroplasticsIBA
12/2021
1HMGB1 Protein (HMG1)IBA
12/2021
13' Untranslated Regions (3' UTR)IBA
12/2021
1Glutamine (L-Glutamine)FDA Link
12/2021
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
12/2021
1AntigensIBA
01/2021
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2021
1Factor VII (Proconvertin)IBA
01/2021
1Bovine Serum AlbuminIBA
12/2019
1Cadherins (E-Cadherin)IBA
12/2019
1Tumor Biomarkers (Tumor Markers)IBA
12/2019
1Doxycycline (Periostat)FDA LinkGeneric
09/2019
1Epithelial Cell Adhesion MoleculeIBA
02/2019
1NSC 74859IBA
01/2019
1Biological FactorsIBA
01/2019
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
12/2018
1Fetal Proteins (Fetoprotein)IBA
12/2017
1DNA (Deoxyribonucleic Acid)IBA
12/2017
1ChromatinIBA
01/2017
1p38 Mitogen-Activated Protein KinasesIBA
06/2016
1Glucose (Dextrose)FDA LinkGeneric
06/2016
1Phosphotransferases (Kinase)IBA
06/2016
1CholesterolIBA
08/2015
1EnzymesIBA
08/2015
1Squalene Monooxygenase (Squalene Epoxidase)IBA
08/2015
1Capsules (Microcapsules)IBA
05/2015
1Heparin (Liquaemin)FDA LinkGeneric
07/2012
1Messenger RNA (mRNA)IBA
08/2009

Therapy/Procedure

9Hepatectomy
11/2023 - 12/2017
5Therapeutics
02/2024 - 06/2016
3Immunotherapy
02/2024 - 12/2021
2Adjuvant Chemotherapy
03/2022 - 01/2022
1Transplantation
01/2023
1Lymph Node Excision (Lymph Node Dissection)
01/2023
1Radiofrequency Ablation
01/2020
1Drug Therapy (Chemotherapy)
08/2015
1Liver Transplantation
07/2012